Leaflet RYTMONORM 70mg / 20ml solution for injection

Product code:
W62339001
Quantity:
5
Indicated for:
cardiac arrhythmias
Route of administration:
injectable
Substance:
propafenone (antiarrhythmic)
ATC
C01BC03 — Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic

Precautions:

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.

Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.

General data about RYTMONORM 70mg / 20ml

Substance:
propafenone
Date of latest medicines list:
01-08-2023
Product code:
W62339001
Concentration:
70mg / 20ml
Pharmaceutical form:
solution for injection
Packing volume:
20ml
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
FAMAR HEALTH CARE SERVICES MADRID, S.A.U. - SPANIA
Holder:
MYLAN HEALTHCARE GMBH - GERMANIA
Number:
7094/2014/01
Shelf life:
3 years

Concentrations available for propafenone

  • 150mg
  • 300mg
  • 35mg/10ml
  • 70mg/20ml